Cyclerion Therapeutics (CYCN) Change in Receivables (2019 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Change in Receivables of -$425000.0 in Q3 2025, down 658.93% quarter-over-quarter from -$56000.0 in Q2 2025.
Cyclerion Therapeutics (CYCN) Change in Receivables (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Change in Receivables history runs 7 years deep, the most recent figure standing at -$425000.0 for Q3 2025.
- In Q3 2025, Change in Receivables changed N/A year-over-year to -$425000.0; the TTM figure through Sep 2025 stood at $100000.0 (changed N/A YoY), while the FY2024 annual figure was $556000.0, up 679.17% from the prior year.
- Change in Receivables was -$425000.0 for Q3 2025 at Cyclerion Therapeutics, down from -$56000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $556000.0 in Q4 2024 to a low of -$425000.0 in Q3 2025.
- Historically, Change in Receivables has averaged $9090.9 across 5 years, with a median of -$56000.0 in 2025.
- Biggest YoY gain for Change in Receivables was 200.0% in 2022; the steepest drop was 157.71% in 2022.
- A 5-year view of Change in Receivables shows it stood at $227000.0 in 2021, then slumped by 157.71% to -$131000.0 in 2022, then climbed by 26.72% to -$96000.0 in 2023, then jumped by 679.17% to $556000.0 in 2024, then tumbled by 176.44% to -$425000.0 in 2025.
- The last three Change in Receivables figures came in at -$425000.0 (Q3 2025), -$56000.0 (Q2 2025), and $25000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -425,000.00 |
| Sep 30, 2025 | -425,000.00 |
| Jun 30, 2025 | -56,000.00 |
| Jun 30, 2025 | -56,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 556,000.00 |
| Dec 31, 2024 | 556,000.00 |
| Jun 30, 2023 | -96,000.00 |
| Jun 30, 2023 | -96,000.00 |
| Dec 31, 2022 | -131,000.00 |
| Dec 31, 2022 | -131,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Sep 30, 2022 | 127,000.00 |
| Jun 30, 2022 | -127,000.00 |
| Jun 30, 2022 | -127,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Mar 31, 2022 | 127,000.00 |
| Dec 31, 2021 | 227,000.00 |
| Dec 31, 2021 | 227,000.00 |